MGM
AFIB

Miura Global Management’s Acutus Medical Inc AFIB Stock Holding History

Miura Global Management’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,000
Closed -$144K – 51
2020
Q4 		$144K Hold
5,000
– – 0.03% 43
2020
Q3 		$149K Buy
+5,000
New +$152K 0.04% 40

Other funds holding AFIB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Miura Global Management's AFIB Position: Q1 2021 in Review

Miura Global Management sold out of Acutus Medical Inc (AFIB) in Q1 2021, closing a stake of 5,000 shares — an estimated $144K sold.

Miura Global Management first reported a position in AFIB in Q3 2020 and held it in 2 quarters. The position peaked at $149K in Q3 2020. 67 funds tracked by Wall St. Rank hold AFIB as of Q1 2021.

  • Miura Global Management reported no remaining Acutus Medical Inc position as of Q1 2021 after selling out during the quarter.
  • Miura Global Management sold 5,000 Acutus Medical Inc shares in Q1 2021, an estimated $144K.
  • Miura Global Management first reported a position in Acutus Medical Inc in Q3 2020 and held it in 2 quarters.
  • Miura Global Management's Acutus Medical Inc position peaked at $149K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2021.

Based on Miura Global Management's 13F filing for Q1 2021, filed 17 May 2021.